Literature DB >> 22584191

Epidemiology of atopic dermatitis: a review.

Sigrid Payne DaVeiga1.   

Abstract

Atopic dermatitis (AD) is a common skin condition with significant associated social and financial burden. AD affects adults and children with worldwide prevalence rates of 1-20%. International study of epidemiology and geographic variability in prevalence of AD has been conducted in three phases with 1,000,000 subjects in the third phase study. Prevalence continues to vary and has changed in different regions of the world. Nigeria, the United Kingdom and New Zealand had been areas of the highest prevalence; Latin America has emerged as a region of relatively high prevalence in follow up data. The prevalence of AD seems to have reached a plateau around 20% in countries with the highest prevalence, suggesting that AD may not be on a continued rise but that a finite number of individuals may be susceptible to the condition. Risk factors associated with increased prevalence include higher socioeconomic status, higher level of family education, smaller family size and urban environment. Research indicates that food allergy and atopic sensitization to environmental allergens may not be directly causal of the condition and that a non-atopic form of the condition exists. ∼60% of patients will experience remission. The number of patients who will progress through the atopic march to develop asthma and allergic rhinitis depends on the underlying features of their condition.

Entities:  

Mesh:

Year:  2012        PMID: 22584191     DOI: 10.2500/aap.2012.33.3569

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  50 in total

1.  Phenotypes of Atopic Dermatitis Depending on the Timing of Onset and Progression in Childhood.

Authors:  Caroline Roduit; Remo Frei; Martin Depner; Anne M Karvonen; Harald Renz; Charlotte Braun-Fahrländer; Elisabeth Schmausser-Hechfellner; Juha Pekkanen; Josef Riedler; Jean-Charles Dalphin; Erika von Mutius; Roger Pascal Lauener; Anne Hyvärinen; Pirkka Kirjavainen; Sami Remes; Marjut Roponen; Marie-Laure Dalphin; Vincent Kaulek; Markus Ege; Jon Genuneit; Sabina Illi; Micahel Kabesch; Bianca Schaub; Petra Ina Pfefferle; Gert Doekes
Journal:  JAMA Pediatr       Date:  2017-07-01       Impact factor: 16.193

Review 2.  Molecular biology of atopic dermatitis.

Authors:  Zhanglei Mu; Yan Zhao; Xiaojing Liu; Christopher Chang; Jianzhong Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

Review 3.  A review of dupilumab in the treatment of atopic diseases.

Authors:  Quinn Thibodeaux; Mary Patricia Smith; Karen Ly; Kristen Beck; Wilson Liao; Tina Bhutani
Journal:  Hum Vaccin Immunother       Date:  2019-03-27       Impact factor: 3.452

4.  Four genetic variants interact to confer susceptibility to atopic dermatitis in Chinese Han population.

Authors:  Changbing Shen; Longdan Liu; Zengqiong Jiang; Xiaodong Zheng; Li Meng; Xianyong Yin; Jing Gao; Yujun Sheng; Jingping Gao; Yang Li; Fusheng Zhou; Fengli Xiao; Liangdan Sun; Yong Cui; Sen Yang; Xianbo Zuo; Xuejun Zhang
Journal:  Mol Genet Genomics       Date:  2015-02-25       Impact factor: 3.291

5.  Whole-Body In Vivo Monitoring of Inflammatory Diseases Exploiting Human Interleukin 6-Luciferase Transgenic Mice.

Authors:  Makiko Hayashi; Jun Takai; Lei Yu; Hozumi Motohashi; Takashi Moriguchi; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2015-08-17       Impact factor: 4.272

Review 6.  Role of viruses in the development of atopic disease in pediatric patients.

Authors:  Dorothy S Cheung; Mitchell H Grayson
Journal:  Curr Allergy Asthma Rep       Date:  2012-12       Impact factor: 4.806

7.  Mechanism for initiation of food allergy: Dependence on skin barrier mutations and environmental allergen costimulation.

Authors:  Matthew T Walker; Jeremy E Green; Ryan P Ferrie; Ashley M Queener; Mark H Kaplan; Joan M Cook-Mills
Journal:  J Allergy Clin Immunol       Date:  2018-02-15       Impact factor: 10.793

8.  Interleukin-4 up-regulation of epidermal interleukin-19 expression in keratinocytes involves the binding of signal transducer and activator of transcription 6 (Stat6) to the imperfect Stat6 sites.

Authors:  Lei Bao; Jaime B Alexander; Vivian Y Shi; Girish C Mohan; Lawrence S Chan
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

9.  Kallikrein 7 Promotes Atopic Dermatitis-Associated Itch Independently of Skin Inflammation.

Authors:  Changxiong J Guo; Madison R Mack; Landon K Oetjen; Anna M Trier; Martha L Council; Ana B Pavel; Emma Guttman-Yassky; Brian S Kim; Qin Liu
Journal:  J Invest Dermatol       Date:  2019-12-26       Impact factor: 8.551

10.  Atopic dermatitis, educational attainment and psychological functioning: a national cohort study.

Authors:  J Smirnova; L B von Kobyletzki; M Lindberg; Å Svensson; S M Langan; S Montgomery
Journal:  Br J Dermatol       Date:  2018-12-05       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.